Ann: OptiScan March 2019 Presentation, page-14

We are closer to numbers without brackets then ever as we do not have all eggs in one basket anymore! The wider market missed it seems like that we have FDA approval for the USA and CE approval for Europe for Carl Zeiss” ConVivo with Optiscan Imaging”s tech in it! The message alone 2 years ago that this will happen in 1 years time gave us already an SP of 12 cents! Now as orders from hospitals in nearly half of the world are created the wider market is still ignoring OIL! Didn’t even mention our second leg we are standing on, our Five2 (ViewnVivo) yet! What an opportunity to step in!